Clément Le Guyadec

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Créapharm SAS manufactures pharmaceuticals and clinical supplies. It formulates, analyses and production of GMP clinical trials batches, both in sterile liquid or lyophilized form and in capsules, including over encapsulation. The company was founded on August 5, 1999 and is headquartered in Gannat, France.

Elyan Partners SAS is a financial investment advisor registered in the unique register maintained by the ORIAS of insurance, banking, and financial intermediaries. Elyan is located at 47, rue du Faubourg Saint Honoré, 75401 Cedex 08, and is controlled by its management team. The private company is based in Paris, France. The French company is the exclusive advisor of Edmond de Rothschild Private Equity for the ERES III and ERES IV funds and advisor of the Privilege 2018 fund. The company benefits from the support of the Edmond de Rothschild group as a minority shareholder. ERES IV invests in mid-sized companies in the biotech ecosystem, online commerce, financial services, and new consumers. Edmond de Rothschild Private Equity creates and develops differentiated investment strategies that provide a lasting response to environmental and social challenges. The company was founded in 2021, and the CEOs are Jean-François Félix and Jérémie Mélin.